Efficacy and safety of immune checkpoint inhibitors in neoadjuvant chemotherapy for triple-negative breast cancer：a systematic review and meta-analysis | Zendy

AI Assistant Blog Pricing

Efficacy and safety of immune checkpoint inhibitors in neoadjuvant chemotherapy for triple-negative breast cancer：a systematic review and meta-analysis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.